Results 21 to 30 of about 22,295,129 (298)
Frontiers in Psychiatry, 2021 This study compares the efficacy and tolerability of central nervous system (CNS) stimulants in children with attention deficit hyperactivity disorder (ADHD) with and without prominent irritability (IRR) over the course of 30 months.
Raman Baweja +4 more
doaj +1 more source
Revista Mexicana de Neurociencia, 2022 Objective: The objective of the study was to know the opinion and prevalence of use of central nervous system stimulant drugs (SDs) in healthy people in open population.
Paulina Flores-Medina +1 more
doaj +1 more source
General overview on sleep medication [PDF]
Romanian Journal of Neurology, 2018 There are many medications that cross the blood-brain barrier affecting the central nervous system and converting the normal patterns of sleep and wakefulness. Some drugs are used to treat special sleep disorders, but others can induce sleep disorders (e.
Floriana Boghez, Ioana Mindruta
doaj +1 more source
Peptidylarginine deiminases and extracellular vesicles: prospective drug targets and biomarkers in central nervous system diseases and repair. [PDF]
, 2021 Peptidylarginine deiminases are a family of calcium-activated enzymes with multifaceted roles in physiological and pathological processes, including in the central nervous system.
Lange, Sigrun
core +1 more source
Divergent effect of fluoxetine on the response to physical or chemical stressors in zebrafish [PDF]
PeerJ, 2017 Fluoxetine is a selective serotonin reuptake inhibitor that increases serotonin concentration in the central nervous system and modulates various systems, including the control of sympathetic outflow and the hypothalamus–pituitary–adrenal. However, it is
Murilo S. Abreu +4 more
doaj +2 more sources
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 [PDF]
BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19.
GBD 2021 Nervous System Disorders Collaborators +1 more
core +5 more sources
Central Nervous System Vasculitis
, 2023 Central nervous system vasculitis (CNSV) is a group of disorders leading to inflammatory vasculopathy within the brain, spinal cord, and leptomeninges. CNSV is divided into primary angiitis of the central nervous system (PACNS) and secondary CNSV based ...
Ken Uchino +5 more
core +1 more source
Healthline, 2023 Considering the growing public health significance of some forms of caffeine use, such as the consumption of energy drinks with high caffeine content that are currently largely unregulated or combinations of caffeine and methamphetamine, the ...
Hetal Rathod
doaj +1 more source
Severe muscle pain and stiffness due to dexmethylphenidate
Clinical Case Reports, 2020 Dexmethylphenidate, and potentially other methylphenidates used in the treatment of attention deficit hyperactivity disorder (ADHD), may cause severe muscle pain and stiffness.
Jacob J. Kon, Alexander A. Kon
doaj +1 more source
Repetitive stimulation in the central nervous system [PDF]
Spinal Cord, 1983 There has been a considerable change in ideas about the effect of a lesion in the central nervous system (CNS) and the view of a fixed neurological deficit following a lesion in the CNS is no longer tenable. The clinical picture seen after a partial lesion in the CNS depends in part on the destruction or partial destruction of nerve pathways and cells,
openaire +2 more sources